Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Is Oaktree Ocsl Stock Slowing Down Price At 12.01 Up 1.35 20260410 Kytx Stock Analysis Kyverna Therapeutics Inc. Biotech Mild Daily Gain 8.87 Performance Outlook 20260403 1 Will Uipath Path Stock Fall Further Path Q1 2026 Earnings Uipath Inc. Posts 0.3 Eps Topping 0.2597 Consensus Estimate 20260408 1 What News Is Impacting Woori Wf Stock Wf Q4 Earnings Beats Estimates By 419.49 20260413 1 Is Rezolve Ai Rzlv Stock Stabilizing Price At 2.61 Down 7.45 20260409 DCOMP Dime Pref A Q1 2026 earnings fall short with EPS missing estimates by 56 management highlights deposit growth momentum GRCE Grace Therapeutics Inc posts narrower Q1 2026 loss than projections shares edge higher on positive investor reception How XTI Aerospace XTIA manages tail risk exposure Q4 2025 Earnings Fall Short REFI Chicago beats Q1 earnings estimates by 54 shares rise 293 on strong performance NCDL Nuveen shares rise modestly as Q4 2025 narrow EPS beat offsets steep year over year revenue decline Netflix Inc NFLX Announces 25 Billion Expanded Share Repurchase Program Following 13 PostEarnings Share Decline mF MFI Stock Is It a Strong Investment Case Underperforming 20260420 Columbus Acq COLA Stock Is It Slowing Down Columbus Acq posts 017 EPS 0M revenue no estimates BLDP Ballard posts Q4 2025 earnings beat shares rise 7 percent on 425 percent year over year revenue growth Materials Select Sector SPDR Fund XLB Positioned for Upside Amid Citis Defensive Global Equity Strategy Overhaul The growth story Westport WPRT is not telling investors Trend Weakens 20260508 WCN Waste reports slight Q1 2026 EPS beat shares drop 167 percent in regular trading today QUCY Mainz beats EPS estimates by 26 yet stock slides 3 despite cost discipline as revenue drops Exxon Mobil Corporation XOM Peer Comparison Analysis Evaluating Dividend Value Proposition Against Chevron CVX Immuneering Reports Q1 2026 Financial Results Highlights Promising Pancreatic Cancer Data Ahead of ASCO 2026 Algonquin AQN Stock Analysis 204 Loss Key Levels 20260515 Lifeward LFWD Q1 2026 Earnings Miss by Significant Key Takeaways Cent Pac Fin CPF Stock Down 155 Support Test at 3197 20260515 Repligen Corporation RGEN Q1 2026 Earnings Beat Revenue NA EPS 048 Hondas EV Strategy Shift Industry Implications Not as Dire as Feared Enpro NPO Reports Strong Q1 2026 Revenue NA EPS Beats CEO Appointment Signals Commercial Expansion Push for Brenmiller Energys BNRG360 Strategy Alussa Energy Acquisition Corp II ALUB Holds Steady at 1001 as Support and Resistance Levels Define Range Archer ADM Crushes Q1 2026 Estimates EPS 071 Tops Views MMYT Q1 2026 Earnings EPS Misses Estimates Amid Mixed Market Reaction Comstock Res CRK Stock Analysis 535 Loss Key Levels 20260520 Cruz and Cantwells Potential College Football Legislation Raises Industry Concerns Berkshire Hathaway Overhauls Portfolio 26 Billion Delta Stake and 224 Alphabet Boost UK and Six Gulf States Sign 37B Trade Agreement Unlocking 580M in Tariff Savings Amazon Allegedly Generated Millions Through Policy Later Deemed Illegal US Jobless Claims Remain Low Signaling Continued Labor Market Resilience SIGA Q1 2026 Earnings Net Loss of 005 per Share as Revenue Figures Remain Undisclosed LNG Q1 2026 Earnings Massive EPS Miss as Company Reports Loss of 1675 per Share MSA Safety MSA Q1 2026 Earnings Solid EPS Beat Amid Steady Demand MGM Q1 2026 Earnings EPS Miss Triggers Cautious Optimism as Shares Advance Hope Bancorp HOPE Q1 2026 Earnings Modest EPS Beat Amidst Quiet Revenue Picture Southside Bancshares SBSI Shows Modest Gains as Stock Hovers Near Key Support Levels TotalEnergies TTE Slides 08 as Selling Pressure Intensifies Near Key Resistance OMS Energy Technologies OMSE Holds Near Support After Modest Gains Consolidation Phase in Focus Liberty Broadband LBRDA Slips 267 as Selling Pressure Intensifies Near Key Support Prologis Inc PLD Q1 2026 Outperformance And Upgraded FullYear Guidance Reshape NearTerm Investment Thesis KTTA Pasithea Therapeutics shares climb 21 percent despite reporting a far wider than expected Q4 2025 per share loss Is MFS MGF stock cyclical or defensive Why First FHN leadership matters more than you think Investor Concern 20260508 Estrella Immunopharma ESLA Stock Changing Trend Institutional Selling 20260427